Compare Gigacloud Technology Inc (GCT) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs IDEXX Laboratories, Inc. — how do they compare? Gigacloud Technology Inc trades at $57.26 (market cap $2.02B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 20× Gigacloud Technology Inc's market cap, and Gigacloud Technology Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| GCT | IDXX | |
|---|---|---|
Market Cap | $2.02B | $40.43B |
Volume | 1,020,985 | 692,164 |
Sector | Technology | Health |
52-Week High | $57.26 | $766.68 |
52-Week Low | $25.46 | $504.70 |
Typical Hold Time | 21 Days | 46 Days |
Enterprise Value | $2.14B | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GCT trades at $56.42, up 0.82% with strong technical momentum as moving averages signal bullish alignment. The company demonstrates robust fundamentals with consistent earnings beats, 10.65% net margins, and 32.34% ROE. Revenue growth from $1.29B to $1.5B projected for 2026 supports valuation at 13.44 P/E. Recent news highlights institutional interest and European expansion driving optimism.
Outlook remains positive given earnings momentum and reasonable valuation, though risks include insider selling and competitive pressures. Analyst consensus favors Buy with $32.50 target, but current price exceeds consensus suggesting cautious near-term positioning may be warranted despite strong operational performance.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
